Cita APA

Casasnovas Pons, C., Ruiz, M., Schlüter, A., Naudi, A., Fourcade, S., Veciana, M., . . . Pujol, A. (2019). Biomarker Identification, Safety, and Efficacy of High-Dose Antioxidants for Adrenomyeloneuropathy: A Phase II Pilot Study.

Citación estilo Chicago

Casasnovas Pons, Carlos, et al. Biomarker Identification, Safety, and Efficacy of High-Dose Antioxidants for Adrenomyeloneuropathy: A Phase II Pilot Study. 2019.

Cita MLA

Casasnovas Pons, Carlos, et al. Biomarker Identification, Safety, and Efficacy of High-Dose Antioxidants for Adrenomyeloneuropathy: A Phase II Pilot Study. 2019.